Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

NCT00616317 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-12-05

No results posted yet for this study

Summary

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Conditions

  • Antiphospholipid Syndrome

Sponsors & Collaborators

  • Ministry of Higher Education, Science and Technology, Solvenia

    collaborator OTHER_GOV
  • University of California, Davis

    lead OTHER

Principal Investigators

  • Lavjay Butani, M.D. · University of California, Davis

Eligibility

Min Age
1 Minute
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2040-01-31
Completion
2040-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00616317 on ClinicalTrials.gov